This site is intended for healthcare professionals

Sign in
Go to /sign-in page

You can view 5 more pages without signing in

Pizotifen

Authoring team

Pizotifen is used in the prophylaxis of migraine. It is an antihistamine and serotonin antagonist structurally related to the tricyclic antidepressants.

Pizotifen can cause weight gain due to appetite stimulation.

For more complete information on migraine prophylaxis, please consult BNF.

A guideline concerning the management of migraine has described pizotifen as a prophylactic agent with limited evidence of efficacy (1).

  • Pizotifen is a popular treatment for migraine prevention in the UK, especially in children and young people. It has been in use since the 1970s and appears to be well tolerated. Inadequate evidence was found in the review for this guideline for the effectiveness of pizotifen in the prophylaxis of migraine

Reference:

  1. NICE (December 2021) Headaches in over 12s: diagnosis and management (CG150)

Related pages

Create an account to add page annotations

Create a free account

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.